Chi-squared test showed that expression levels of FEZF1-AS1 in NSCLC tissues were significantly correlated with patients’ clinical stage and tumor grades, but not patients’ gender, age, subtypes and drinking and smoking habits (Table 1). The gene discussed is FEZF1; the disease is non-small cell lung carcinoma.